SE427353B - Forfarande for framstellniong av terapeutiskt aktiva derivat av ditiepino-(1,4) (2,3-c)-pyrrol - Google Patents

Forfarande for framstellniong av terapeutiskt aktiva derivat av ditiepino-(1,4) (2,3-c)-pyrrol

Info

Publication number
SE427353B
SE427353B SE7701843A SE7701843A SE427353B SE 427353 B SE427353 B SE 427353B SE 7701843 A SE7701843 A SE 7701843A SE 7701843 A SE7701843 A SE 7701843A SE 427353 B SE427353 B SE 427353B
Authority
SE
Sweden
Prior art keywords
ditiepino
pyrrol
procedure
preparation
therapeutically active
Prior art date
Application number
SE7701843A
Other languages
English (en)
Swedish (sv)
Other versions
SE7701843L (sv
Inventor
C Jeanmart
A Leger
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7604713A external-priority patent/FR2341312A1/fr
Priority claimed from FR7635096A external-priority patent/FR2371198A2/fr
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE7701843L publication Critical patent/SE7701843L/xx
Publication of SE427353B publication Critical patent/SE427353B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7701843A 1976-02-20 1977-02-18 Forfarande for framstellniong av terapeutiskt aktiva derivat av ditiepino-(1,4) (2,3-c)-pyrrol SE427353B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7604713A FR2341312A1 (fr) 1976-02-20 1976-02-20 Nouveaux derives du dithiepinno (1,4) (2,3-c) pyrrolle, leur preparation et les compositions qui les contiennent
FR7635096A FR2371198A2 (fr) 1976-11-22 1976-11-22 Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
SE7701843L SE7701843L (sv) 1977-08-21
SE427353B true SE427353B (sv) 1983-03-28

Family

ID=26219306

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701843A SE427353B (sv) 1976-02-20 1977-02-18 Forfarande for framstellniong av terapeutiskt aktiva derivat av ditiepino-(1,4) (2,3-c)-pyrrol

Country Status (23)

Country Link
US (1) US4124711A (he)
JP (1) JPS52100495A (he)
AR (1) AR218261A1 (he)
AT (1) AT350577B (he)
AU (1) AU503745B2 (he)
CA (1) CA1072557A (he)
CH (1) CH620443A5 (he)
DE (1) DE2707072C2 (he)
DK (1) DK146069C (he)
ES (2) ES456041A1 (he)
FI (1) FI61190C (he)
GB (1) GB1512620A (he)
HU (1) HU172292B (he)
IE (1) IE44564B1 (he)
LU (1) LU76799A1 (he)
NL (1) NL7701487A (he)
NO (1) NO145539C (he)
NZ (1) NZ183366A (he)
PH (1) PH12628A (he)
PT (1) PT66203B (he)
SE (1) SE427353B (he)
SU (2) SU869559A3 (he)
YU (2) YU39990B (he)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451380A1 (fr) * 1979-03-15 1980-10-10 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
ATE39483T1 (de) * 1982-04-02 1989-01-15 Takeda Chemical Industries Ltd Kondensierte pyrrolinon-derivate, und ihre herstellung.
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
ZA756953B (en) * 1974-11-07 1976-10-27 Rhone Poulenc Ind 1,4-oxathiino(2,3-c)pyrrole derivatives

Also Published As

Publication number Publication date
GB1512620A (en) 1978-06-01
AU503745B2 (en) 1979-09-20
FI61190B (fi) 1982-02-26
HU172292B (hu) 1978-07-28
ES457260A1 (es) 1978-06-01
JPS52100495A (en) 1977-08-23
YU39990B (en) 1985-06-30
SE7701843L (sv) 1977-08-21
FI61190C (fi) 1982-06-10
NO145539B (no) 1982-01-04
DE2707072A1 (de) 1977-08-25
NO770552L (no) 1977-08-23
FI770530A (he) 1977-08-21
YU40082B (en) 1985-06-30
NZ183366A (en) 1978-09-20
PT66203A (fr) 1977-03-01
ES456041A1 (es) 1978-05-01
CH620443A5 (he) 1980-11-28
DK146069C (da) 1983-11-14
DE2707072C2 (de) 1985-09-12
DK71877A (da) 1977-08-21
LU76799A1 (he) 1977-09-12
AR218261A1 (es) 1980-05-30
ATA109977A (de) 1978-11-15
AU2240177A (en) 1978-08-24
YU45877A (en) 1982-10-31
SU869559A3 (ru) 1981-09-30
JPS6145625B2 (he) 1986-10-08
PT66203B (fr) 1978-08-12
CA1072557A (fr) 1980-02-26
IE44564B1 (en) 1982-01-13
AT350577B (de) 1979-06-11
US4124711A (en) 1978-11-07
NL7701487A (nl) 1977-08-23
PH12628A (en) 1979-07-05
SU674672A3 (ru) 1979-07-15
DK146069B (da) 1983-06-20
YU162782A (en) 1982-10-31
NO145539C (no) 1982-04-14
IE44564L (en) 1977-08-20

Similar Documents

Publication Publication Date Title
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
MX3565E (es) Procedimiento de preparacion de derivados de la tieno(2,3-c)-piridina
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO151362C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater.
NO150361C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(1h-tetrazol-5-yl)-4h-(pyrido-(1,2-a)-pyrimidin-4-on-derivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO159019C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater.
SE7701460L (sv) Forfarande for framstellning an nya derivat av 1,2-ditiol
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
SE7701459L (sv) Forfarande for framstellning av nya derivat av 1,2-ditiol
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
AR218498A1 (es) Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
SE7700533L (sv) Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinonderivat
SE427353B (sv) Forfarande for framstellniong av terapeutiskt aktiva derivat av ditiepino-(1,4) (2,3-c)-pyrrol
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO149209C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(3-(3,4,5-trimetoksyfenoksy)-2-hydroksypropyl))-4-aryl-piperazin-derivater
NO153729C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydro-trans-4a,9b-1(h)pyridoindolderivater.
AR211854A1 (es) Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
SE417091B (sv) Forfarande att framstella farmakologiskt aktiva derivat av 2-karboxialkyl-4,4dimetyl-pyrrolidin-5-on
SE415657B (sv) Forfarande for framstellning av terapeutiskt aktiva derivat av 4-(2-hydroxi-3-amino-propoxi)indol
NO143534C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol.
NO154497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyranokinolinonderivater.
SE7702166L (sv) Forfarande for framstellning av derivat av cyklopenta (b) tiofen

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7701843-0

Effective date: 19880125

Format of ref document f/p: F